Breast Cancer Research and Treatment

Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer?
pp. 259-268(10)
Authors: Hurria, Arti; Lachs, Mark

Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
pp. 269-281(13)
Authors: Uematsu, Takayoshi; Yuen, Sachiko; Kasami, Masako; Uchida, Yoshihiro

Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer
pp. 283-291(9)
Authors: Heller, Gerwin; Geradts, Joseph; Ziegler, Barbara; Newsham, Irene; Filipits, Martin; Markis-Ritzinger, Eva-Maria; Kandioler, Daniela; Berger, Walter; Stiglbauer, Wolfgang; Depisch, Dieter; Pirker, Robert; Zielinski, Christoph; Zöchbauer-Müller, Sabine

The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model
pp. 293-302(10)
Authors: Goss, Paul; Qi, Shangle; Hu, Haiqing; Cheung, Angela

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy
pp. 303-311(9)
Authors: Silverman, Daniel; Dy, Christine; Castellon, Steven; Lai, Jasmine; Pio, Betty; Abraham, Laura; Waddell, Kari; Petersen, Laura; Phelps, Michael; Ganz, Patricia

Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy
pp. 313-318(6)
Authors: Yonemori, Kan; Katsumata, Noriyuki; Kaneko, Masayuki; Uno, Hajime; Matsumoto, Koji; Kouno, Tsutomu; Shimizu, Chikako; Ando, Masashi; Takeuchi, Masahiro; Fujiwara, Yasuhiro

Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients
pp. 319-329(11)
Authors: Feng, Yumei; Sun, Baocun; Li, Xiaoqing; Zhang, Liang; Niu, Yun; Xiao, Chunhua; Ning, Liansheng; Fang, Zhiyi; Wang, Yuli; Zhang, Lina; Cheng, Jing; Zhang, Wei; Hao, Xishan

Melatonin and estrogen in breast cyst fluids
pp. 331-341(11)
Authors: Burch, James; Walling, Margie; Rush, Adam; Hennesey, Maxine; Craven, Winfield; Finlayson, Christina; Anderson, Benjamin; Cosma, Greg; Wells, Robert

Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women
pp. 343-348(6)
Authors: Reinier, Kyndaron; Vacek, Pamela; Geller, Berta

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil
pp. 349-353(5)
Authors: Gomes, Magda; Costa, Mauricio; Borojevic, Radovan; Monteiro, Alvaro; Vieira, Roberto; Koifman, Sergio; Koifman, Rosalina; Li, Song; Royer, Robert; Zhang, Shiyu; Narod, Steven

CDKN2A-positive breast cancers in young women from Poland
pp. 355-359(5)
Authors: Dębniak, Tadeusz; Cybulski, Cezary; Górski, Bohdan; Huzarski, Tomasz; Byrski, Tomasz; Gronwald, Jacek; Jakubowska, Anna; Kowalska, Elżbieta; Oszurek, Oleg; Narod, Steven; Lubiński, Jan

Diet quality and BRCA-associated breast cancer risk
pp. 361-369(9)
Authors: Nkondjock, A.; Ghadirian, P.

Does breast cancer associated with CHEK2 1100delC carry characteristics of basal phenotype?
pp. 371-371(1)
Authors: Dede, Didem; Sari, Ebru; Bulut, Nilufer; Altundag, Kadri

Progesterone, progestins, pregnancy and breast cancer risk
pp. 373-374(2)
Author: Ferretti, Gianluigi